Electra Therapeutics (ETRA) eyes $325 million Nasdaq IPO at $14 to $16

Electra Therapeutics aims for a $977.6M valuation in its U.S. IPO, offering 21.67M shares at $14-$16 each, raising up to $346.7M. The biotech company develops therapies for immunological diseases and cancer, with proceeds funding clinical trials. It plans to list on Nasdaq as 'ETRA'.

Londian Wason (NYSE: FOIL) raised $108.06M in total IPO proceeds, including $13.77M from additional ADS sales at $22.00 each. The company, a global manufacturer of electrolytic copper foil, plans to use funds for expansion, R&D, and general corporate purposes. It is a key supplier to Panasonic and a leader in lithium battery copper foil sales.

SB Energy, a SoftBank-backed AI infrastructure platform, plans to raise up to $500 million in Japan as part of its U.S. IPO, expected between September 2026 and February 2027. The company aims to raise $5 billion to $7 billion in total, according to The Wall Street Journal. It will trade on Nasdaq under the symbol SBE.

Bamboo Insurance Services Inc. aims to raise up to $700 million in an IPO, selling 35 million shares at $18-$20 each. The company reported $14 million in net income and $173 million in revenue for the first half of 2026. It plans to list on the NYSE under the ticker 'BMB'.

Bamboo is offering 35 million shares in its IPO at $18-$20 each, with proceeds going to CVC and White Mountains. The company reported $173M revenue in H1 2026, up 40% YoY, but net income fell to $13.8M. Bamboo aims to list on NYSE under ticker 'BMB'. It operates in California's shrinking admitted insurance market, focusing on wildfire-prone areas.

Bamboo Insurance Services plans to IPO 35 million Class A shares at $18-$20 per share, listing on NYSE as BMB. Existing investors CVC and White Mountains will sell shares, with underwriters having a 30-day option for more. J.P. Morgan and Morgan Stanley lead the offering.